Trademarkia Logo

Canada

C$
FERU-GUARD
REGISTERED

on 12 Feb 2020

Last Applicant/ Owned by

GLOVIA COMPANY LTD.

2-9-6-7F ShinkawaChuo-ku, Tokyo

JP

Serial Number

1812269 filed on 1st Dec 2016

Registration Number

TMA1072543 registered on 12th Feb 2020

Registration expiry Date

12th Feb 2030

Correspondent Address

SMART & BIGGAR LP

550 Burrard Street, Suite 1900Vancouver

BRITISH COLUMBIA

CA

V6C3A8

FERU-GUARD

Trademark usage description

pharmaceuticals, namely pharmaceutical preparations for the treatment and prevention of development disorder, namely, autism spectrum disorder (former Read More

Classification Information


Class [005]
Pharmaceuticals, namely pharmaceutical preparations for the treatment and prevention of development disorder, namely, Autism Spectrum Disorder (Formerly Asperger's, Autistic Disorder, & Rett's), Attachment Disorder, Attention Deficit/Hyperactivity Disorder (ADHD/ADD), Conduct Disorder, Disorder of Written Expression, Disruptive Mood Dysregulation Disorder, Encopresis, Enuresis, Expressive Language Disorder, Mathematics Disorder, Intellectual Disability, Oppositional Defiant Disorder, Reading Disorder, Rumination Disorder, Selective Mutism Separation Anxiety Disorder, Social (Pragmatic) Communication Disorder, Stereotypic Movement Disorder, Tourette's Disorder, and Transient Tic Disorder, dementia, neurodegenerative disease, namely, Ataxia-telangiectasia, Autosomal dominant cerebellar ataxia, Autosomal recessive spastic ataxia of Charlevoix-Saguenay, Baggio-Yoshinari syndrome, Batten disease, Cell-Cycle Hypothesis of Alzheimer's Disease, Corticobasal degeneration, Corticobasal syndrome, Creutzfeldt-Jakob disease, Estrogen disorders having a neurodegenerative basis, Fatal insomnia, Fragile X-associated tremor/ataxia syndrome, Dementia and Parkinson's Disease, Hereditary motor and sensory neuropathy with proximal dominance, Infantile Refsum disease, Kufor-Rakeb syndrome, Kufs disease, Locomotor ataxia, Lyme disease, Machado-Joseph disease, Microcephaly with pontine and cerebellar hypoplasia, Mitochondria associated membranes, Multiple system atrophy, Neuroacanthocytosis, Niemann-Pick disease, Occupational exposure to Lyme disease, Pontocerebellar hypoplasia, Protein aggregation, Pyruvate dehydrogenase deficiency, Refsum disease, Sandhoff disease, Shy-Drager syndrome, Spinocerebellar ataxia, Subacute combined degeneration of spinal cord, Subacute sclerosing panencephalitis T, Tabes dorsalis, Tay-Sachs disease, Toxic encephalopathy, Toxic leukoencephalopathy, Transneuronal degeneration, Wobbly hedgehog syndrome, Amyotrophic lateral sclerosis, Friedreich's ataxia, and Lewy body disease and depression; empty capsules for pharmaceuticals; lacteal flour for babies; dietary supplements for humans for the treatment and prevention of development disorder, namely, Autism Spectrum Disorder (Formerly Asperger's, Autistic Disorder, & Rett's), Attachment Disorder, Attention Deficit/Hyperactivity Disorder (ADHD/ADD), Conduct Disorder, Disorder of Written Expression, Disruptive Mood Dysregulation Disorder, Encopresis, Enuresis, Expressive Language Disorder, Mathematics Disorder, Intellectual Disability, Oppositional Defiant Disorder, Reading Disorder, Rumination Disorder, Selective Mutism Separation Anxiety Disorder, Social (Pragmatic) Communication Disorder, Stereotypic Movement Disorder, Tourette's Disorder, and Transient Tic Disorder, dementia, neurodegenerative disease, namely, Ataxia-telangiectasia, Autosomal dominant cerebellar ataxia, Autosomal recessive spastic ataxia of Charlevoix-Saguenay, Baggio-Yoshinari syndrome, Batten disease, Cell-Cycle Hypothesis of Alzheimer's Disease, Corticobasal degeneration, Corticobasal syndrome, Creutzfeldt-Jakob disease, Estrogen disorders having a neurodegenerative basis, Fatal insomnia, Fragile X-associated tremor/ataxia syndrome, Dementia and Parkinson's Disease, Hereditary motor and sensory neuropathy with proximal dominance, Infantile Refsum disease, Kufor-Rakeb syndrome, Kufs disease, Locomotor ataxia, Lyme disease, Machado-Joseph disease, Microcephaly with pontine and cerebellar hypoplasia, Mitochondria associated membranes, Multiple system atrophy, Neuroacanthocytosis, Niemann-Pick disease, Occupational exposure to Lyme disease, Pontocerebellar hypoplasia, Protein aggregation, Pyruvate dehydrogenase deficiency, Refsum disease, Sandhoff disease, Shy-Drager syndrome, Spinocerebellar ataxia, Subacute combined degeneration of spinal cord, Subacute sclerosing panencephalitis T, Tabes dorsalis, Tay-Sachs disease, Toxic encephalopathy, Toxic leukoencephalopathy, Transneuronal degeneration, Wobbly hedgehog syndrome, Amyotrophic lateral sclerosis, Friedreich's ataxia, and Lewy body disease and depression; dietetic beverages adapted for medical purposes, namely dietetic beverages for medical use for the treatment and prevention of development disorder, namely, Autism Spectrum Disorder (Formerly Asperger's, Autistic Disorder, & Rett's), Attachment Disorder, Attention Deficit/Hyperactivity Disorder (ADHD/ADD), Conduct Disorder, Disorder of Written Expression, Disruptive Mood Dysregulation Disorder, Encopresis, Enuresis, Expressive Language Disorder, Mathematics Disorder, Intellectual Disability, Oppositional Defiant Disorder, Reading Disorder, Rumination Disorder, Selective Mutism Separation Anxiety Disorder, Social (Pragmatic) Communication Disorder, Stereotypic Movement Disorder, Tourette's Disorder, and Transient Tic Disorder, dementia, neurodegenerative disease, namely, Ataxia-telangiectasia, Autosomal dominant cerebellar ataxia, Autosomal recessive spastic ataxia of Charlevoix-Saguenay, Baggio-Yoshinari syndrome, Batten disease, Cell-Cycle Hypothesis of Alzheimer's Disease, Corticobasal degeneration, Corticobasal syndrome, Creutzfeldt-Jakob disease, Estrogen disorders having a neurodegenerative basis, Fatal insomnia, Fragile X-associated tremor/ataxia syndrome, Dementia and Parkinson's Disease, Hereditary motor and sensory neuropathy with proximal dominance, Infantile Refsum disease, Kufor-Rakeb syndrome, Kufs disease, Locomotor ataxia, Lyme disease, Machado-Joseph disease, Microcephaly with pontine and cerebellar hypoplasia, Mitochondria associated membranes, Multiple system atrophy, Neuroacanthocytosis, Niemann-Pick disease, Occupational exposure to Lyme disease, Pontocerebellar hypoplasia, Protein aggregation, Pyruvate dehydrogenase deficiency, Refsum disease, Sandhoff disease, Shy-Drager syndrome, Spinocerebellar ataxia, Subacute combined degeneration of spinal cord, Subacute sclerosing panencephalitis T, Tabes dorsalis, Tay-Sachs disease, Toxic encephalopathy, Toxic leukoencephalopathy, Transneuronal degeneration, Wobbly hedgehog syndrome, Amyotrophic lateral sclerosis, Friedreich's ataxia, and Lewy body disease and depression; dietetic food adapted for medical purpose, namely dietetic food for medical use for the treatment and prevention of development disorder, namely, Autism Spectrum Disorder (Formerly Asperger's, Autistic Disorder, & Rett's), Attachment Disorder, Attention Deficit/Hyperactivity Disorder (ADHD/ADD), Conduct Disorder, Disorder of Written Expression, Disruptive Mood Dysregulation Disorder, Encopresis, Enuresis, Expressive Language Disorder, Mathematics Disorder, Intellectual Disability, Oppositional Defiant Disorder, Reading Disorder, Rumination Disorder, Selective Mutism Separation Anxiety Disorder, Social (Pragmatic) Communication Disorder, Stereotypic Movement Disorder, Tourette's Disorder, and Transient Tic Disorder, dementia, neurodegenerative disease, namely, Ataxia-telangiectasia, Autosomal dominant cerebellar ataxia, Autosomal recessive spastic ataxia of Charlevoix-Saguenay, Baggio-Yoshinari syndrome, Batten disease, Cell-Cycle Hypothesis of Alzheimer's Disease, Corticobasal degeneration, Corticobasal syndrome, Creutzfeldt-Jakob disease, Estrogen disorders having a neurodegenerative basis, Fatal insomnia, Fragile X-associated tremor/ataxia syndrome, Dementia and Parkinson's Disease, Hereditary motor and sensory neuropathy with proximal dominance, Infantile Refsum disease, Kufor-Rakeb syndrome, Kufs disease, Locomotor ataxia, Lyme disease, Machado-Joseph disease, Microcephaly with pontine and cerebellar hypoplasia, Mitochondria associated membranes, Multiple system atrophy, Neuroacanthocytosis, Niemann-Pick disease, Occupational exposure to Lyme disease, Pontocerebellar hypoplasia, Protein aggregation, Pyruvate dehydrogenase deficiency, Refsum disease, Sandhoff disease, Shy-Drager syndrome, Spinocerebellar ataxia, Subacute combined degeneration of spinal cord, Subacute sclerosing panencephalitis T, Tabes dorsalis, Tay-Sachs disease, Toxic encephalopathy, Toxic leukoencephalopathy, Transneuronal degeneration, Wobbly hedgehog syndrome, Amyotrophic lateral sclerosis, Friedreich's ataxia, and Lewy body disease and depression; beverages for babies; food for babies; dietary supplements for animals, namely animal feed supplements and protein supplements for animals


Classification kind code

10

Mark Details


Serial Number

1812269

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 26
on 25th Oct 2019
Approved
Submitted for opposition 27
on 25th Oct 2019
Approval Notice Sent
Submitted for opposition 67
on 11th Sept 2019
Agent Name Changed
Submitted for opposition 15
on 21st Aug 2018
Correspondence Created
Submitted for opposition 12
on 26th Apr 2018
Extension of Time
Submitted for opposition 22
on 29th Sept 2017
Search Recorded
Submitted for opposition 20
on 29th Sept 2017
Examiner's First Report
Submitted for opposition 1
on 2th Dec 2016
Created
Submitted for opposition 31
on 2th Dec 2016
Formalized
Submitted for opposition 30
on 1st Dec 2016
Filed